The factor xa inhibitor edoxaban for the prevention of stroke and systemic embolism in patients with atrial fibrillation

  • Joan Minguet, Helen M Sims, Katherine H Smith, Peter Bramlage
  • Expert Review of Clinical Pharmacology, November 2016, Taylor & Francis
  • DOI: 10.1080/17512433.2016.1258301

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/17512433.2016.1258301

The following have contributed to this page: Peter Bramlage